España
India
Italia
대한민국
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Screeners
Stock Screener
Top Momentum Stocks
Top Quality Stocks
Top Value Stocks
Top Growth Stocks
Recent
Markets
Stock Trading Ideas
Analyst Warns Starbucks Faces Growing Risks From Competition, Costs, and Global Tensions
Analyst Says Trade Desk Can Shake Off Challenges, Ride Streaming's Next Big Wav
Regeneron Pharma Margins Tighten As Competition Grows, Stock Slides
Analyst Says Trade Desk Can Shake Off Challenges, Ride Streaming's Next Big Wav
Regeneron Pharma Margins Tighten As Competition Grows, Stock Slides
Why Is Hilton Worldwide Stock Trading Higher on Tuesday?
Microsoft Q3 Earnings: Azure May Rise 30% - That's Not Where 'CTOs Are Aggressively Spending' Analyst Warns
Why Is Hilton Worldwide Stock Trading Higher on Tuesday?
Microsoft Q3 Earnings: Azure May Rise 30% - That's Not Where 'CTOs Are Aggressively Spending' Analyst Warns
Rare Bullish Signal Just Flashed On Wall Street: Will It Power S&P 500 To 6,000?
Meta Q1 Earnings On Deck: Expert Sees Growth At A 'Reasonable Price'
Read More...
Trading Ideas Recent News
MicroStrategy Stock Up 2.9% After Key Signal At 10:12 AM
A significant trading signal occurred for MicroStrategy stock at 10:12 AM today, at a price of $373.20, after which MSTR rose up to 2.9%.
Viant Gains Analyst Praise For Household ID, CTV Tools Amid Ad Market Rebound
Analyst initiates Viant with a Buy rating, citing its innovative ad tech, Household ID graph, and potential upside amid improving macro trends.
Readers Correctly Predicted Tesla Earnings – Here's Their View On Apple Stock
After correctly predicting that Tesla would miss quarterly estimates from analysts, Benzinga readers share their take on Apple stock ahead of Q2 results.
CEO Speak: Okeanis Eco Tankers CEO Aristides Alafouzos Discusses Company and Tanker Sector Outlook for 2025
Okeanis Eco Tankers CEO Aristides Alafouzos discusses company and tanker sector outlook for 2025.
Snap Hits 900 Million Users, Beats Q1 Estimates, But Stock Slides On 'Uncertainty'
Breaking down the highlights from Snap Inc's Q1 financial results and a look at what's next.
Meta Platforms Q1 Earnings Preview: Analyst Expects Weak Guidance, Will Company Continue Streak Of Revenue Beats?
Analysts are lowering their price targets on Meta Platforms ahead of Q1 results. Will the company report a weak report and guidance?
Microsoft Q3 Earnings Preview: Cloud, AI, Guidance Top Items Analysts Highlight To Watch
Analysts have caution on Microsoft's guidance ahead of Q3 results. Will cloud and AI growth outshine cautious expectations?
Western Digital Refocuses Post-SanDisk Spin-Off As Analyst Highlights AI-Led HDD Growth
Rosenblatt analyst maintains Buy on Western Digital, lowers price target to $50. Expects profitable growth in HDD market driven by AI and cloud demand.
6 Stocks Showing Momentum As The Market Rebounds
Hims & Hers Stock Surges As It Collaborates With Novo Nordisk To Sell Weight Loss Drug Wegovy On Its Platform
Hims & Hers partners with Novo Nordisk to offer Wegovy access online with clinical support, expanding its weight loss care and revenue strategy.
Crude Oil Down Over 2%; Pfizer Shares Gain After Q1 Earnings
Stock Market Ignoring Tariff Pull Forward But Prudent Investors Should Not
To gain an edge, this is what you need to know today.
Progressive's Pain May Turn To Gain As Tariff Inflation Creates A Surprising Tailwind
Progressive Corp (PGR) stock underperforms S&P 500, but upgraded to Buy by analyst Joshua Shanker with a higher price target of $312 due to strong auto insurance growth and potential tariff-induced inflation.
Stock Of The Day: AbbVie's Rally Looks Stretched — Could A Reversal Be Next?
Shares of AbbVie (ABBV) have gained more than 12% in the past week. But now they are overbought and may reverse.
Snap Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
This Arista Networks Analyst Is No Longer Bearish; Here Are Top 2 Upgrades For Tuesday